Display options
Share it on

Kidney Int Suppl (2011). 2014 Nov;4(1):65-69. doi: 10.1038/kisup.2014.12.

Platelet-derived growth factors (PDGFs) in glomerular and tubulointerstitial fibrosis.

Kidney international supplements

Tammo Ostendorf, Peter Boor, Claudia R C van Roeyen, Jürgen Floege

Affiliations

  1. Department of Nephrology, RWTH University of Aachen , Aachen, Germany.
  2. Department of Nephrology, RWTH University of Aachen , Aachen, Germany ; Institute of Pathology, RWTH University of Aachen , Aachen, Germany ; Institute of Molecular Biomedicine, Comenius University , Bratislava, Slovakia.

PMID: 26312152 PMCID: PMC4536969 DOI: 10.1038/kisup.2014.12

Abstract

Renal fibrosis is the hallmark of chronic kidney disease progression and is characterized by an exaggerated wound-healing process with the production of renal scar tissue. It comprises both the glomerular and the tubulointerstitial compartments. Among the factors that contribute to kidney fibrosis, the members of the platelet-derived growth factor (PDGF) family are among the best characterized ones. They appear to be the key factors in driving renal fibrosis, independent of the underlying kidney disease. The PDGF family consists of four isoforms (PDGF-A, -B, -C, and -D) and two receptor chains (PDGFR-α and -β), which are constitutively or inducibly expressed in most renal cells. These components have an irreplaceable role in kidney development by recruitment of mesenchymal cells to the glomerular and tubulointerstitial compartments. They further regulate multiple pathophysiologic processes including cell proliferation, cell migration, expression and accumulation of extracellular matrix, production and secretion of pro- and anti-inflammatory mediators, vascular permeability, and hemodynamics. This review provides a brief update on the role of different PDGF isoforms in the development of glomerulosclerosis and tubulointerstitial fibrosis, newly identified endogeneous PDGF antagonists, and resulting potential therapies.

Keywords: extracellular matrix; glomerulosclerosis; mesangial cell; mesenchymal cells; myofibroblast

References

  1. Stem Cells. 2009 Aug;27(8):1712-21 - PubMed
  2. Nephrol Dial Transplant. 2007 Dec;22(12):3391-407 - PubMed
  3. Kidney Int. 2002 Dec;62(6):2043-54 - PubMed
  4. Nat Rev Nephrol. 2010 Nov;6(11):643-56 - PubMed
  5. Am J Pathol. 2013 Jan;182(1):107-17 - PubMed
  6. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1281-5 - PubMed
  7. Kidney Int. 2011 Dec;80(11):1170-81 - PubMed
  8. J Am Soc Nephrol. 2008 Jan;19(1):12-23 - PubMed
  9. Cytokine Growth Factor Rev. 2004 Aug;15(4):205-13 - PubMed
  10. J Am Soc Nephrol. 2003 Sep;14(9):2237-47 - PubMed
  11. FASEB J. 2005 Jan;19(1):1-11 - PubMed
  12. Am J Pathol. 2010 Feb;176(2):839-49 - PubMed
  13. J Am Soc Nephrol. 2008 Feb;19(2):281-9 - PubMed
  14. Hum Pathol. 2008 Mar;39(3):393-402 - PubMed
  15. Nephrol Dial Transplant. 2009 Sep;24(9):2755-62 - PubMed
  16. Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3012-7 - PubMed
  17. Int J Clin Pharmacol Ther. 2008 May;46(5):236-44 - PubMed
  18. J Am Soc Nephrol. 2003 Oct;14(10):2544-55 - PubMed
  19. J Am Soc Nephrol. 2003 May;14(5):1145-53 - PubMed
  20. J Am Soc Nephrol. 2004 Feb;15(2):286-98 - PubMed
  21. Pediatr Nephrol. 2012 Jul;27(7):1041-50 - PubMed
  22. Kidney Int. 2008 Jan;73(1):86-94 - PubMed
  23. Kidney Int. 2013 Feb;83(2):251-63 - PubMed
  24. Genes Dev. 2008 May 15;22(10):1276-312 - PubMed
  25. Kidney Int. 2011 Dec;80(12):1292-305 - PubMed
  26. Eur J Cell Biol. 2012 Jun-Jul;91(6-7):542-51 - PubMed
  27. J Am Soc Nephrol. 2002 Apr;13(4):910-7 - PubMed
  28. Am J Pathol. 1996 Apr;148(4):1169-80 - PubMed
  29. Am J Pathol. 2010 Jul;177(1):58-69 - PubMed
  30. Nephrol Dial Transplant. 2007 May;22(5):1323-31 - PubMed
  31. J Clin Invest. 2006 Jun;116(6):1561-70 - PubMed
  32. J Biol Chem. 2004 May 7;279(19):19732-8 - PubMed
  33. Am J Pathol. 2012 May;180(5):1979-90 - PubMed
  34. Am J Hypertens. 2001 May;14(5 Pt 1):439-45 - PubMed
  35. Nephrol Dial Transplant. 2013 Apr;28(4):889-900 - PubMed

Publication Types